PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-20

Date Title Company
20-Oct-2025 SOM Biotech secures clear registrational path for SOM3355 in Huntington’s disease after FDA End‑of‑Phase 2 Meeting Andrew Lloyd Associates
20-Oct-2025 Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO Businesswire
20-Oct-2025 A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus ACCESS Newswire
20-Oct-2025 Med-X to Exhibit its Nature-Cide Division at the PestWorld Conference in Orlando from October 21-24, 2025 ACCESS Newswire
20-Oct-2025 Stemtech Corporation Backorders Filled ACCESS Newswire
20-Oct-2025 Genentech’s Tecentriq Showed Significant Overall and Disease-Free Survival Benefits in Bladder Cancer With ctDNA-Guided Treatment Businesswire
20-Oct-2025 Health Impact Alliance and Connect America Announce "LifelineConnect" to Transform Senior Independence ACCESS Newswire
20-Oct-2025 FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis Businesswire
20-Oct-2025 Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline ACCESS Newswire
20-Oct-2025 ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors ImmunOs Therapeutics
20-Oct-2025 Sustainability and innovation key themes across Lab Innovations’ speaker lineup Lab Innovations
20-Oct-2025 HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026 ACCESS Newswire
20-Oct-2025 Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi's Online ADHD Diagnostic Evaluation Validation Study ACCESS Newswire
20-Oct-2025 Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors ACCESS Newswire
20-Oct-2025 Updated BEXMAB Phase I/II Data Presented at ESMO 2025 Shows Further Improvement, Strengthening the Clinical Profile of Bexmarilimab in Treatment-Naïve HR-MDS Patients ACCESS Newswire
20-Oct-2025 Genflow Biosciences PLC Announces Recognition of Patentability of Claims ACCESS Newswire